换一批Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
第一作者：
E,de Jonge
第一单位：
Department of Intensive Care, Laboratory of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Central Laboratory of the Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.
作者：
医学主题词
成年人(Adult);抗凝药(Anticoagulants);抗凝血酶Ⅲ(Antithrombin III);血液凝固(Blood Coagulation);血压(Blood Pressure);体温(Body Temperature);交叉研究(Cross-Over Studies);细胞因子类(Cytokines);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);内毒素血症(Endotoxemia);大肠杆菌感染(Escherichia coli Infections);纤维蛋白溶解(Fibrinolysis);心率(Heart Rate);人类(Humans);输注, 静脉内(Infusions, Intravenous);注射, 静脉内(Injections, Intravenous);脂多糖类(Lipopolysaccharides);脂蛋白类(Lipoproteins);男(雄)性(Male);肽水解酶类(Peptide Hydrolases);纤溶酶原激活物抑制物1(Plasminogen Activator Inhibitor 1)
PMID
10666180
发布时间
2021-02-16
- 浏览44
Blood
1124-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
